MTruong.. I see, I misread this.. thanks for clari
Post# of 148184
I actually am starting to think the FDA realizes LLMab is the only treatment for severe we've got, and don't want to waste supply. Pure conjecture. But the FDA guidance seems very deliberate/specific... there is a reason for that, and that seems like the simplest explanation.
Quote:
Is it because they don't consider moderate ARDS as an emergency scenario? Either they are trying to save LL for the sickest of sick or handicapping LL from achieving good results.
Read More: https://investorshangout.com/post/view?id=600...z6iK91fXwo